Threats in bioterrorism II: CDC category B and C agents

Emergency Medicine Clinics of North America

Volumn 20, Issue 2, 2002, Pages 311-330

  Moran, Gregory J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BCG VACCINE; CHOLERA VACCINE; CIPROFLOXACIN; CLOSTRIDIUM TOXIN; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE; PAROMOMYCIN; Q FEVER VACCINE; QUINOLINE DERIVATIVE; RIBAVIRIN; RIFAMPICIN; SALMONELLOSIS VACCINE; STAPHYLOCOCCUS ENTEROTOXIN B; TETRACYCLINE; TICK BORNE ENCEPHALITIS VACCINE; TUBERCULOSTATIC AGENT; YELLOW FEVER VACCINE;

BIOLOGICAL WARFARE; BRUCELLOSIS; CHOLERA; CLINICAL FEATURE; CRYPTOSPORIDIUM; DISEASE TRANSMISSION; EARLY DIAGNOSIS; EMERGENCY TREATMENT; ENCEPHALOMYELITIS; ENVIRONMENTAL EXPOSURE; ESCHERICHIA COLI O157; HANTAVIRUS; HORSE DISEASE; HUMAN; INFECTION CONTROL; LETHALITY; MORBIDITY; MORTALITY; NIPAH VIRUS; PRIORITY JOURNAL; PROPHYLAXIS; Q FEVER; REVIEW; SALMONELLA; SALMONELLOSIS; SHIGELLA; TICK BORNE ENCEPHALITIS; TUBERCULOSIS; VACCINATION; YELLOW FEVER;

EID: 0036309781     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(01)00003-7     Document Type: Article

References (40)

1. Biological and chemical terrorism: Strategic plan for preparedness and response
2. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases
3. The chest film findings in Q fever - A series of 35 cases
4. Treatment of Q fever
5. Clinical recognition and management of patients exposed to biological warfare agents
6. Overview of brucellosis
7. Misidentification of Brucella species with use of rapid bacterial identification systems
8. The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable?
9. Laboratory-acquired human glanders Maryland, May 2000
10. Glanders in a military research microbiologist
11. Biological warfare in the twentieth century: Lessons from the past, challenges for the future
12. Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei
13. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test
14. Clinical and neurologic manifestations of eastern equine encephalitis
15. Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses
16. Ricin
17. Castor bean intoxication
18. Quantification of ricin toxin using a highly sensitive avidin/biotin enzyme-linked immunosorbent assay
19. Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres
20. Gas gangrene and other clostridium-associated diseases
21. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination
22. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars
23. Emerging infectious diseases: Outbreak of Salmonella enteritidis associated with nationally distributed ice cream products-Minnesota, South Dakota, and Wisconsin, 1994
24. Multistate outbreak of listeriosis-United States, 2000
25. Diagnosis and management of foodborne illnesses: A primer for physicians
26. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply
27. Escherichia coli O157:H7
28. Update: Outbreak of Nipah virus, Malaysia and Singapore, 1999
29. Laboratory diagnosis of Nipah and Hendra virus infections
30. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia
31. Treatment of acute Nipah encephalitis with ribavirin
32. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness
33. Hantavirus pulmonary syndrome: Clinical description of disease caused by a newly recognized hemorrhagic fever virus in the southwestern United States
34. Evaluation of two commercially available immunoassays for the detection of hantavirus antibodies in serum samples
35. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus
36. An unusual hantavirus outbreak in southern Argentina: Person-to-person transmission?
37. Hantavirus pulmonary syndrome in the United States
38. Yellow fever: A medically neglected disease
39. Flaviviruses
40. Management of tuberculosis in the United States